This guideline updates and widens the scope of the previ-ous British Society for Haematology (BSH) Clinical guide-lines for Diagnosis and Management of Heparin-Induced Thrombocytopenia: Second Edition1 to include functional assays in the diagnosis of heparin-induced thrombocy...
McLornan, Donal P;
Psaila, Bethan;
Ewing, Joanne;
Innes, Andrew;
Arami, Siamak;
Brady, Jessica;
Butt, Nauman M;
Cargo, Catherine;
Cross, Nicholas C. P;
Francis, Sebastian;
Frewin, Rebecca;
Garg, Mamta;
Godfrey, Anna L;
Green, Anna;
Khan, Alesia;
Knapper, Steve;
Lambert, Jonathan;
McGregor, Andrew;
McMullin, Mary Frances;
Nangalia, Jyoti;
Neelakantan, Pratap;
Woodley, Claire;
Mead, Adam;
Somervaille, Tim C. P;
Harrison, Claire N.
This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015 These guidelines aim to pro-vide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF)...
Walewska, Renata;
Eyre, Toby A.;
Barrington, Sally;
Brady, Jessica;
Fields, Paul;
Iyengar, Sunil;
Joshi, Anurag;
Menne, Tobias;
Parry-Jones, Nilima;
Walter, Harriet;
Wotherspoon, Andrew;
Linton, Kim.
The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL)....
McLornan, Donal P;
Godfrey, Anna L;
Green, Anna;
Frewin, Rebecca;
Arami, Siamak;
Brady, Jessica;
Butt, Nauman M;
Cargo, Catherine;
Ewing, Joanne;
Francis, Sebastian;
Garg, Mamta;
Harrison, Claire;
Innes, Andrew;
Khan, Alesia;
Knapper, Steve;
Lambert, Jonathan;
Mead, Adam;
McGregor, Andrew;
Neelakantan, Pratap;
Psaila, Bethan;
Somervaille, Tim C. P;
Woodley, Claire;
Nangalia, Jyoti;
Cross, Nicholas C. P;
McMullin, Mary Frances.
This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary m...
Dementia is a clinical syndrome of cognitive decline that includes a range of cognitive and
behavioural symptoms caused by a variety of underlying pathophysiological processes. This
includes Alzheimer’s disease, vascular dementia, mixed dementia, dementia with Lewy bodies and
frontotemporal dementia.1,...
Scully, M;
Rayment, R;
Clark, A;
Westwood, J. P;
Cranfield, T;
Gooding, R;
Bagot, C. N;
Taylor, A;
Sankar, V;
Gale, D;
Dutt, T;
McIntyre, J;
Lester, W.
The objective of this guideline is to provide healthcare professionals with clear, up-to-date and practical guidance on the management of thrombotic thrombocytopenic purpura (TTP) and related thrombotic microangiopathies (TMAs), including complement-mediated haemolytic uraemic syndrome (CM HUS); these ar...
Evidence-based recommendations on automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers....
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new inter...
Early value assessment (EVA) guidance on point-of-care tests for urinary tract infections to improve antimicrobial prescribing.
Guidance development process
Early value assessment (EVA) guidance rapidly provides recommendations on promising health technologies that have the potential to address national...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Esclerosis Múltiple/terapia,
Esclerosis Múltiple/diagnóstico,
Ataxia/terapia,
Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico,
Fatiga/terapia,
Esclerosis Múltiple/rehabilitación,
Fatiga/tratamiento farmacológico,
Limitación de la Movilidad,
Espasticidad Muscular/tratamiento farmacológico,
Distonía/tratamiento farmacológico,
Temblor/tratamiento farmacológico
